AS News

Latest breaking news and updates for AS stock.

Track all markets on TradingView

Amer Sports Reports Second Quarter 2025 Financial Results, Raises Full Year Revenue, Margin, and EPS Guidance

NEW YORK--(BUSINESS WIRE)--Amer Sports, Inc. (NYSE: AS) (“Amer Sports” or the “Company”) today announced its financial results for the second quarter of 2025. CEO James Zheng commented, "Amer Sport...

How does Amer Sports' Q2 performance and outlook compare to its peers in the sports and outdoor equipment sector? What impact could the higher tariffs and near‑term macro uncertainty have on the company's cost structure and profitability? How will the raised full‑year revenue, margin, and EPS guidance affect Amer Sports' valuation and target price?
Earnings
21 days ago
Read more businesswire

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

- The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in body weight compared to tirzepatide monotherapy. - ASC47 low dose in co...

How might the combination therapy pricing be structured, and what impact could that have on profit margins and reimbursement prospects? What are the competitive risks if other companies also develop muscle‑preserving weight‑loss agents targeting the same mechanism? How robust is the preclinical data—e.g., sample size, reproducibility, and relevance to human obesity physiology?
Clinical trials
28 days ago
Read more prnewswire